XRF System analyzes pharmaceutical catalysts.
Share:
Press Release Summary:
Featuring benchtop design, Epsilon 1 XRF provides out-of-the-box pre-calibrated solution for analysis of residual catalysts in pharmaceutical materials. Fully integrated, energy dispersive XRF analyzer consists of spectrometer, built-in computer, and touchscreen. System produces accurate data with minimal operator dependence and sample preparation.
Original Press Release:
PANalytical to Launch New Compact Benchtop XRF System for Pharmaceutical Catalysts Analysis at AAPS Conference 2014
PANalytical, Almelo, the Netherlands: PANalytical will launch a new Epsilon 1 XRF (X-ray fluorescence) analyzer at this year’s meeting of the American Association of Pharmaceutical Sciences (AAPS), November 2-6, in San Diego, California. Designed as the most powerful benchtop spectrometer in its class, the new Epsilon 1 provides a compact and cost-effective ‘out-of-the-box’ pre-calibrated solution for the analysis of residual catalysts in pharmaceutical materials.
Metal catalysts are used as part of the pharmaceutical development and manufacturing processes. Post-process efforts are made to remove the undesired catalyst from the material but there are often residues remaining. These residues require comprehensive quantification to meet stringent industry permissible limits, such as those specified in pharmacopoeias including the United States pharmacopoeia and the European pharmacopoeia. The Epsilon 1 will set the new benchmark for analytical performance and ease of use in this class of industry-dedicated XRF instrumentation.
“The need for pharmaceutical catalyst analysis is an industry-wide concern,” commented Pieter de Groot, PANalytical Corporate Marketing Director. “The Epsilon 1 offers a pre-calibrated total solution package, including installation qualification and operation qualification procedures. Designed with simplicity in mind, for the first time PANalytical’s high standards of analysis are now available in this class of desktop instruments.”
For more information on PANalytical’s innovative range of X-ray based analytical techniques and additive analysis solutions visit the PANalytical website at www.panalytical.com.
About PANalytical
PANalytical’s mission is to enable people to get valuable insight into their materials and processes. Our customers can be found in virtually every industry segment, from building materials to pharmaceuticals and from metals and mining to nanomaterials. The combination of our software and instrumentation, based on X-ray diffraction (XRD), X-ray fluorescence (XRF), near-infrared (NIR) and optical emission (OES) spectroscopy and pulsed fast thermal neutron activation (PFTNA), provides our customers with highly reliable and robust elemental and structural information on their materials and is applied in scientific research and industrial process and quality control.
PANalytical employs over 1,000 people worldwide. The company’s headquarters are in Almelo, the Netherlands. Fully equipped application laboratories are established in Japan, China, the US, Brazil, and the Netherlands. PANalytical’s research activities are based in Almelo (NL) and on the campus of the University of Sussex in Brighton (UK). Supply and competence centers are located on two sites in the Netherlands: Almelo (X-ray instruments) and Eindhoven (X-ray tubes), in Nottingham, UK (XRF applications and standards), in Quebec, Canada (fusion sample preparation) and in Boulder, CO, US (near-infrared instruments).
PANalytical is active in all but a few countries of the world. This worldwide sales and service network ensures unrivalled levels of customer support.
The company is certified in accordance with ISO 9001 and ISO 14001.
Visit www.panalytical.com for more information about our activities.
PANalytical is part of Spectris plc, the productivity-enhancing instrumentation and controls company.
For more press and product information please contact:
Jeantine Bakker
Corporate Marketing & Communications
T +31 (0)546 534444
F +31 (0)546 534598
info@panalytical.com
